Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Brazil

Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, São Paulo

Rheumatology Division, Faculdade de Medicina da USP, São Paulo, São Paulo